Interestingly, breast tumor samples with somatic damaging (nonsense, frameshift or missense) mutations in BRCA1 or BRCA2 genes showed a higher expression of Signature-3 score than tumors with BRCA1/2 wt genes (Supplementary Table S3). This evidence concerns the gene BRCA1 and breast neoplasm.